Among the total 6 GC patients we investigated, there were five cases in which FSCN1 was up-regulated along with the down-regulation of miR-133b in GC tissues indicating that miR-133b suppress the expression of FSCN1 in these patients (Figure 6E). The gene discussed is FSCN1; the disease is gastric cancer.